Our study was the first to screen 42 genetic variants and ultimately combine four APOA-I SNPs and five APOB SNPs (using the GRS model) to comprehensively examine the genetic roles of APOA-I and APOB in insulin resistance and MetS in OSA. Here, APOA1 is linked to metabolic syndrome.